{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:33:36Z","timestamp":1773088416782,"version":"3.50.1"},"reference-count":77,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2023,5,3]]},"DOI":"10.1080\/14656566.2023.2198640","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T08:09:15Z","timestamp":1680941355000},"page":"815-824","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacological management of systemic sclerosis associated interstitial lung disease"],"prefix":"10.1080","volume":"24","author":[{"given":"Giles","family":"Dixon","sequence":"first","affiliation":[{"name":"Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK"},{"name":"Academic Respiratory Unit, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Adamali","sequence":"additional","affiliation":[{"name":"Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huzaifa","family":"Adamali","sequence":"additional","affiliation":[{"name":"Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK"},{"name":"Academic Respiratory Unit, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaney","family":"Barratt","sequence":"additional","affiliation":[{"name":"Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK"},{"name":"Academic Respiratory Unit, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsha","family":"Gunarwardena","sequence":"additional","affiliation":[{"name":"Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK"},{"name":"Department of Rheumatology, North Bristol NHS Trust, Bristol, UK"},{"name":"Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Pauling","sequence":"additional","affiliation":[{"name":"Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK"},{"name":"Department of Rheumatology, North Bristol NHS Trust, Bristol, UK"},{"name":"Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-016-3636-7"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22204"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.07.025"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.114264"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40027"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.091710"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.176.3.2389033"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02026-2019"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370904"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38390"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370903"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.04.006"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00005512"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055120"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30152-7"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151322"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903076"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00232-4"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30318-0"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key213"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00107-7"},{"key":"e_1_3_4_25_1","first-page":"suppl 9","article-title":"Rituximab versus Cyclophosphamide for the Treatment of Connective Tissue Disease Associated Interstitial Lung Disease (RECITAL): A Sub-group Analysis of a Multi-centre Randomised Controlled Trial","volume":"74","author":"TV MT","year":"2022","unstructured":"TV MT, Saunders P, Gibbons M, et al. Rituximab versus Cyclophosphamide for the Treatment of Connective Tissue Disease Associated Interstitial Lung Disease (RECITAL): A Sub-group Analysis of a Multi-centre Randomised Controlled Trial. Arthritis Rheumatol. 2022;74(suppl 9) [cited 2023 April 12]. Available from: https:\/\/acrabstracts.org\/abstract\/rituximab-versus-cyclophosphamide-for-the-treatment-of-connective-tissue-disease-associated-interstitial-lung-disease-recital-a-sub-group-analysis-of-a-multi-centre-randomised-controlled-trial\/","journal-title":"Arthritis Rheumatol"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2534"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-0108"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200702-326OC"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30438"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209909"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0374-8"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11125"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1517-z"},{"issue":"3","key":"e_1_3_4_34_1","first-page":"161","article-title":"Intravenous versus oral cyclophosphamide for lung and\/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trials","volume":"38","author":"Bruni C","year":"2020","unstructured":"Bruni C, Tashkin DP, Steen V, et al. Intravenous versus oral cyclophosphamide for lung and\/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trials. Clin Exp Rheumatol. 2020;38(3):161\u2013168.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"e_1_3_4_35_1","first-page":"7","article-title":"Effect of Sequential Intravenous Pulse Cyclophosphamide-Azathioprine in Systemic Sclerosis-Interstitial Lung Disease: an Open-Label Study","volume":"58","author":"Kundu S","year":"2016","unstructured":"Kundu S, Paul S, Hariprasath K, et al. Effect of Sequential Intravenous Pulse Cyclophosphamide-Azathioprine in Systemic Sclerosis-Interstitial Lung Disease: an Open-Label Study. Indian J Chest Dis Allied Sci. 2016;58(1):7\u201310.","journal-title":"Indian J Chest Dis Allied Sci"},{"issue":"6","key":"e_1_3_4_36_1","first-page":"1064","article-title":"Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study","volume":"35","author":"Berezne A","year":"2008","unstructured":"Berezne A, Ranque B, Valeyre D, et al. Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study. J Rheumatol. 2008;35(6):1064\u20131072.","journal-title":"J Rheumatol"},{"issue":"4","key":"e_1_3_4_37_1","first-page":"613","article-title":"Twelve-month azathioprine as maintenance therapy in early diffuse systemic sclerosis patients treated for 1-year with low dose cyclophosphamide pulse therapy","volume":"25","author":"Paone C","year":"2007","unstructured":"Paone C, Chiarolanza I, Cuomo G, et al. Twelve-month azathioprine as maintenance therapy in early diffuse systemic sclerosis patients treated for 1-year with low dose cyclophosphamide pulse therapy. Clin Exp Rheumatol. 2007;25(4):613\u2013616.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40560"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00359-9"},{"issue":"5","key":"e_1_3_4_40_1","first-page":"181","article-title":"Effects of rituximab in connective tissue disorders related interstitial lung disease","volume":"100","author":"Lepri G","year":"2016","unstructured":"Lepri G, Avouac J, Airo P, et al. Effects of rituximab in connective tissue disorders related interstitial lung disease. Clin Exp Rheumatol. 2016;100(5):181\u2013185.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa675"},{"key":"e_1_3_4_42_1","unstructured":"NICE. Skin involvement in systemic sclerosis: rituximab2017."},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200955"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120725"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41668"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202103-0714OC"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab273"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002477"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac136"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41933"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.070112"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-016-0328-5"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2019-0328TR"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm501562a"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30330-1"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42075"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.6368"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703327"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2021.1918864"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-010-0403-6"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc1034"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00107-2020"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30289-3"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-1912-9"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209868"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201501-034OC"},{"issue":"3","key":"e_1_3_4_68_1","first-page":"CD011008","article-title":"Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness","volume":"3","author":"Barnes H","year":"2016","unstructured":"Barnes H, McDonald J, Smallwood N, et al. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev. 2016;3(3):CD011008.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.11.939"},{"key":"e_1_3_4_70_1","unstructured":"NHS Scotland. Scottish palliative care guidelines. 2021 [cited 2023 April 12]. https:\/\/www.palliativecareguidelines.scot.nhs.uk\/"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201111-2042ST"},{"issue":"10","key":"e_1_3_4_72_1","first-page":"CD007354","article-title":"Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults","volume":"10","author":"Simon ST","year":"2016","unstructured":"Simon ST, Higginson IJ, Booth S, et al. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev. 2016;10(10):CD007354.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_73_1","unstructured":"NICE. Palliative care - dyspnoea http:\/\/cks.nice.org.uk\/topics\/palliative-care-dyspnoea2022 ["},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03465"},{"key":"e_1_3_4_75_1","unstructured":"Back I Watson M Armstrong P et al. Palliative Care Adult Network Guidelines. https:\/\/book.Pallcare.info\/index.Php2021"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2009.238"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2106012"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213708"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200706-877OC"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2023.2198640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T08:39:37Z","timestamp":1732091977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2023.2198640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":77,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,5,3]]}},"alternative-id":["10.1080\/14656566.2023.2198640"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2023.2198640","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}